Haverford Trust Co Makes New Investment in Marsh & McLennan Companies, Inc. $MRSH

Haverford Trust Co purchased a new stake in Marsh & McLennan Companies, Inc. (NYSE:MRSH) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 6,955 shares of the financial services provider’s stock, valued at approximately $1,159,000.

Several other hedge funds also recently made changes to their positions in the company. Solstein Capital LLC purchased a new stake in Marsh & McLennan Companies in the fourth quarter valued at approximately $25,000. Asset Dedication LLC purchased a new position in shares of Marsh & McLennan Companies during the first quarter worth approximately $25,000. SHP Wealth Management acquired a new position in shares of Marsh & McLennan Companies in the 4th quarter valued at $26,000. KERR FINANCIAL PLANNING Corp purchased a new stake in Marsh & McLennan Companies in the 4th quarter valued at $27,000. Finally, Golden State Wealth Management LLC acquired a new stake in Marsh & McLennan Companies during the 4th quarter worth $27,000. Hedge funds and other institutional investors own 87.99% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have commented on the company. Piper Sandler reduced their price objective on Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating for the company in a research note on Tuesday, May 26th. Mizuho boosted their target price on Marsh & McLennan Companies from $197.00 to $201.00 and gave the company a “neutral” rating in a report on Wednesday, July 22nd. UBS Group upped their price target on Marsh & McLennan Companies from $212.00 to $216.00 and gave the stock a “buy” rating in a research note on Monday, July 27th. JPMorgan Chase & Co. lifted their price objective on shares of Marsh & McLennan Companies from $206.00 to $212.00 and gave the company an “overweight” rating in a research report on Monday, July 13th. Finally, Cantor Fitzgerald boosted their price objective on shares of Marsh & McLennan Companies from $210.00 to $218.00 and gave the company an “overweight” rating in a research note on Thursday, July 9th. One equities research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, eleven have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Marsh & McLennan Companies presently has an average rating of “Hold” and a consensus target price of $203.50.

Insider Activity at Marsh & McLennan Companies

In related news, Director Lloyd M. Yates sold 12,000 shares of the stock in a transaction that occurred on Thursday, July 23rd. The shares were sold at an average price of $175.65, for a total transaction of $2,107,800.00. Following the completion of the sale, the director owned 12,001 shares of the company’s stock, valued at approximately $2,107,975.65. This represents a 50.00% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO John Q. Doyle sold 16,656 shares of the stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the completion of the sale, the chief executive officer directly owned 116,811 shares of the company’s stock, valued at $18,889,506.81. The trade was a 12.48% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 36,469 shares of company stock valued at $6,291,345 over the last three months. Insiders own 0.38% of the company’s stock.

Marsh & McLennan Companies Stock Performance

MRSH opened at $192.17 on Friday. The company has a debt-to-equity ratio of 1.22, a quick ratio of 1.14 and a current ratio of 1.14. The stock has a market capitalization of $91.71 billion, a P/E ratio of 23.49, a price-to-earnings-growth ratio of 2.75 and a beta of 0.59. Marsh & McLennan Companies, Inc. has a one year low of $156.60 and a one year high of $212.65. The business’s fifty day moving average price is $179.88.

Marsh & McLennan Companies (NYSE:MRSH) last announced its quarterly earnings results on Tuesday, July 21st. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.89 by $0.07. Marsh & McLennan Companies had a net margin of 14.24% and a return on equity of 32.67%. The company had revenue of $7.28 billion for the quarter. The firm’s revenue was up 6.2% compared to the same quarter last year. On average, analysts predict that Marsh & McLennan Companies, Inc. will post 10.43 EPS for the current fiscal year.

Marsh & McLennan Companies Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 14th. Investors of record on Thursday, July 23rd were given a dividend of $0.99 per share. This represents a $3.96 annualized dividend and a yield of 2.1%. This is a boost from Marsh & McLennan Companies’s previous quarterly dividend of $0.90. The ex-dividend date was Thursday, July 23rd. Marsh & McLennan Companies’s dividend payout ratio (DPR) is currently 48.41%.

Marsh & McLennan Companies Company Profile

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.